Video Experimental Relacionado
Updated: Feb 2, 2026
06:26
Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
853
Estudio prospectivo multicéntrico de cohortes sobre resultados clínicos y patrones de fibrosis en subtipos de
Gi-Ae Kim1, Heejoon Jang2, Moon Young Kim3
1Division of Gastroenterology and Hepatology, Department of Internal Medicine, College of Medicine, Kyung Hee University Hospital, Kyung Hee University, Seoul, South Korea.
Gastroenterology
|January 31, 2026
Resumen
La enfermedad hepática esteatósica asociada a disfunción metabólica (MASLD) y la enfermedad hepática alcohólica (ALD) aumentan significativamente la mortalidad y los eventos hepáticos. Los distintos patrones de fibrosis en MASLD, MetALD y ALD resaltan vías de progresión únicas.
Área de la Ciencia:
- Hepatología
- Investigación de Enfermedades Hepáticas
- Análisis de Fibrosis
Sus antecedentes:
- Los subtipos de enfermedad hepática esteatósica (SLD), que incluyen la enfermedad hepática esteatósica asociada a disfunción metabólica (MASLD), la enfermedad hepática relacionada con disfunción metabólica y alcohol (MetALD) y la enfermedad hepática alcohólica (ALD), tienen resultados clínicos y características histológicas poco estudiados.
- Comprender estas diferencias es crucial para un diagnóstico y manejo precisos del paciente.
Objetivo del estudio:
- Investigar y comparar los resultados clínicos y los patrones de fibrosis en MASLD, MetALD y ALD.
- Identificar características histológicas y perfiles de riesgo distintos asociados con cada subtipo de SLD.
Principales métodos:
- Un estudio multicéntrico prospectivo de cohortes de 2551 individuos con SLD probada por biopsia o controles no SLD.
- Evaluación de la mortalidad por todas las causas, eventos hepáticos (LRE), enfermedad cardiovascular y neoplasias malignas extrahepáticas utilizando modelos de Fine-Gray.
- Análisis cuantitativo de fibrosis (qFibrosis) basado en IA en biopsias hepáticas para evaluar la distribución de colágeno específica de zona.
Principales resultados:
- MetALD y ALD mostraron riesgos sustancialmente mayores de mortalidad por todas las causas y LRE en comparación con los controles no SLD.
- En fibrosis avanzada, ALD presentó un mayor riesgo de mortalidad y LRE que MASLD.
- El análisis de IA reveló patrones distintos de deposición de colágeno en MetALD y ALD, particularmente en las regiones periportal y de la zona 2, a pesar de una estadificación de fibrosis convencional similar.
Conclusiones:
- MetALD y ALD están independientemente relacionados con riesgos significativamente mayores de mortalidad y LRE.
- Los patrones únicos de colágeno específicos de zona en MetALD y ALD sugieren vías de progresión fibrótica distintas.
- Los hallazgos respaldan la necesidad de estratificación de riesgos y estrategias de manejo personalizadas para los diferentes subtipos de SLD.
Palabras clave:
Consumo de alcoholInteligencia artificialFibrosisPronósticoEnfermedad hepática esteatósicaMás Videos Relacionados
Videos de Conceptos Relacionados
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
589
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
589
01:26Diseases of the Liver and Gallbladder
2.0K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.0K
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
594
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
594
01:24Chronic Kidney Disease II: Clinical Manifestations
651
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
651
01:30Coronary Artery Disease III: Clinical Manifestations
374
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
374
01:29Gastroesophageal Reflux Disease II: Clinical Features and Management
944
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
944